BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24761446)

  • 1. [Postoperative recurrence: adalimumab is an effective standard medication].
    Hofmann-Aßmus M
    Z Gastroenterol; 2014 Mar; 52(3):260. PubMed ID: 24761446
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
    J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can the postoperative relapse of Crohn disease be influenced?].
    Jussila A; Färkkilä M; Järvinen HJ
    Duodecim; 2001; 117(8):817-22; quiz 822, 857. PubMed ID: 12116447
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Busquets D; Aldeguer X
    J Crohns Colitis; 2013 Jun; 7(5):e195. PubMed ID: 23219261
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
    Kotze PG; Yamamoto T
    J Crohns Colitis; 2013 Dec; 7(12):e698. PubMed ID: 23932785
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
    Buisson A; Chevaux JB; Bommelaer G; Peyrin-Biroulet L
    Dig Liver Dis; 2012 Jun; 44(6):453-60. PubMed ID: 22265329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Pediatric Inflammatory Bowel Disease.
    Maxwell EC; Grossman AB
    Adolesc Med State Art Rev; 2016; 27(1):57-74. PubMed ID: 27363233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
    Cossu A; Biancone L; Ascolani M; Pallone F; Boirivant M
    J Crohns Colitis; 2013 Jul; 7(6):441-50. PubMed ID: 22840925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
    Schwartz M; Regueiro M
    Curr Gastroenterol Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21042888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
    Ardizzone S; Bollani S; Manzionna G; Colombo E; Maconi G; Imbesi V; Bianchi Porro G
    Ann Ital Chir; 2003; 74(6):621-5. PubMed ID: 15206802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW; Sandborn WJ
    Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.